Journal Information
Original article
Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study
Experiencia con el uso de baricitinib y tocilizumab en monoterapia o combinados, en pacientes con neumonía intersticial secundaria al coronavirus COVID-19: Un estudio del mundo real
José Rosasa,
, Francisco Pasquau Liañob, Mónica Llombart Cantóc, José María Carrasco Baread, Amparo Raga Besere, José Tomás Algado Rabasab, Francisco Martínez Adsuarf, Brian Vila Aulic, Isabel Fernández Lópezd, Ana María Garijo Sainzb, Pere Esquerdo Ramisb, Laura Ruiz Pérezd, Mª Luisa Navarrete Rebollod, Raquel Hernández Loridog, Laura Gómez Escolarh, COVID19-HMB Group ◊
Corresponding author
a Rheumatology Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
b Internal Medicine Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
c Pneumology Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
d Intensive Care Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
e Pharmacy Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
f Anesthesia Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
g Neurology Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
h Gastroenterology Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain